The ethics of CRISPR gene editing has become a pivotal topic in contemporary discussions of medical innovation and health equity.As scientists harness the power of gene editing technology to potentially cure genetic disorders like sickle cell anemia, profound ethical questions arise regarding the implications of such decisions.